Heterologous expression and characterization of CYP61A1 from dandruff-causing Malassezia globosa

Seul-Ong Ohk1, Hyoung-Goo Park2, Hwayoun Lee2

  • 1College of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea.

Insights

Researchers characterized a key enzyme, CYP61A1, in the dandruff-causing fungus Malassezia globosa. This enzyme binds azole antifungals, suggesting it

Area of Science:

  • Biochemistry
  • Mycology
  • Enzymology

Background:

  • Malassezia globosa is a pathogenic fungus responsible for human skin conditions like dandruff.
  • Cytochrome CYP enzymes in yeasts are crucial for sterol biosynthesis and are targets for azole antifungal drugs.

Purpose of the Study:

  • To express and characterize the MGL_0310 gene product (CYP61A1), a sterol C-22 desaturase in M. globosa.
  • To investigate the potential of CYP61A1 as a therapeutic target for antifungal drug development.

Main Methods:

  • The CYP61A1 gene was amplified from M. globosa DNA and cloned into a pCW vector.
  • Heterologous expression in Escherichia coli, followed by purification using Ni(2+)-NTA affinity chromatography.
  • Characterization involved CO-difference spectroscopy and binding spectral titration with sterols and azole agents.

Main Results:

  • Purified CYP61A1 showed a typical CYP CO-difference spectrum with a peak at 452nm.
  • Binding studies indicated a Type I binding mode for beta-sitosterol and campesterol, with Kd values of 5.4±0.6μM and 6.1±1.0μM, respectively.
  • CYP61A1 exhibited tight binding to azole agents and also bound several fatty acids, suggesting a large active site.

Conclusions:

  • CYP61A1, a sterol C-22 desaturase in M. globosa, tightly binds azole antifungal agents.
  • This enzyme represents a potential therapeutic target for developing new treatments against M. globosa infections, including dandruff.
  • The enzyme's interaction with fatty acids suggests a broad active site, offering insights into fungal sterol biosynthesis.

Related Concept Videos